Truth about topical botox and botox treatments in Calgary, Edmonton and Alberta.

The Truth about Topical Botox®

Truth about topical botox and botox treatments in Calgary, Edmonton and Alberta.

Whether we choose to accept them or not, wrinkles and lines are an inevitable feature as we get older. This is a common concern for men as well as women. We can either choose to accept them or find some way to do something about them. Many people have looked to Botox® treatments for this purpose as this drug has proven to be one of the most effective in altering the effects of wrinkles, crow’s feet and fine lines.

This particular drug is derived from a purified form of Botulin Toxin A. It is administered by a certified doctor or plastic surgeon by way of injections. Needles are inserted at the exact site or close to areas where wrinkles are prevalent. The chemical works by blocking the nerves that contract muscles, thereby softening the appearance of wrinkles. The effects become evident after 3 to 5 days and will last between 3 and 6 months. This means that follow-up treatments are necessary. The good news is that the more Botox® treatments you undergo, the less evident wrinkles will appear as the particular muscles become more or less tense.

Contrary to popular belief, skin tightening treatments are not only used by models and other celebrities. It is common among middle aged working women who want to look refreshed and less stressed. There is also a significant percentage of professional men in their twenties to middle years who also want to appear energetic and for those who are older, more youthful.

The popularity of Botox® treatments is limited only by the common fear held by many of needles. Many of us cringe and become squeamish at the idea of being pricked and at the temporary redness and soreness that follows. Topical alternatives to Botox® treatments are being developed more now than before; and these are producing results that are just as effective.

Topical anti-wrinkle treatments such as RT001 by Revance Therapuetics and Pretox Infin 8 are building anticipation in the market of anti-wrinkle treatments. RT001 is Botox® in cream form that is applied directly to the skin. It is absorbed quickly and then directly targets the over worked muscles which cause wrinkles. This results in a smoother look. This particular drug is just moments away from FDA approval in the United States and is in the final stages of clinical trials in Canada. It was successful in removing crow’s feet with no harmful side effects.

Pretox Infin 8 focuses on reducing the depth of wrinkles and frown lines up to 50%, especially targeting those lines in the forehead and at corners of the eyes. It restores elasticity and collagen, thus having a moisturizing and nourishing effect on skin as well. An immediate tightening effect will be felt upon application but more precise effects will become evident in 6 to 12 weeks.

Topical treatments have several advantages. They are being developed with lowered risk of side effects for the overall safety of users. They can target areas that physicians and plastic surgeons may find it difficult to treat with injections. They are actually best suited for use on the delicate and fairly thinner skin around the eyes and on the forehead. Applications are simple and painless. Usage will become more popular as now an individual can conduct treatments at home without the need to go in for an appointment. They leave a more natural expression and more consistent results. Although cited as alternatives to Botox® injections, topical products can be used as a supplement to injection treatments.

Botox and its Benefits

Botulinum Toxin (Botox®) and its Benefits

Botox and its Benefits

Botox® is a purified protein made by Clostridium botulinum, a bacterium. Botox® is usually injected in tiny amounts and is used in treating muscle spasms and relaxing facial muscles so as to reduce wrinkles. In the recent past, many doctors have discovered many other alternative uses of Botox®. Muscle spasms are treated by injecting the neurotoxin into the muscles where it stiffens and restricts the muscles. The most common use of Botox® is alleviating wrinkles around the eyes, mouth, and forehead areas. But is Botox® just for wrinkles? The answer is No. Other alternative uses of Botox® have been discovered recently and are discussed below.

Alternative uses of Botox®

Relieving Migraines

This is one of the very few uses of Botox® that have been approved by the Federal Drug Agency (FDA). The research to establish the exact function of Botox® in relieving migraines is still being done. However, there exists a theory suggesting that Botox® prevents the nerve endings from sending pain signals to the brain so the migraine will not be felt.

Uncontrolled Blinking

Botox® was initially designed for curing crossed eyes and also the inability to control blinking. This drug was designed to act on the muscles that caused spasm crossing of the eyes by weakening the muscles. A number of patients who had eye conditions treated with Botox® also noticed the wrinkles around their eyes were disappearing. This was the beginning of using Botox® as treatment for wrinkles.

Excessive Sweating

The reduction of sweating is the second most popular use of this drug after wrinkle reduction. Botox® has been found to reduce sweat gland stimulation. These glands are located under the arms and on the palms. Other treatments failed prior to the use of Botox® which after injection in the right areas, it inhibited sweating. This treatment is beneficial for people who have hyperhidrosis.

Neck Muscle Spasms

The uncontrollable movements of muscles have been found to result from the platysma bands which are vertical bands located in the neck region. The discomfort they cause, usually spasms, and the platysma bands appearance have been improved by using Botox® and physical therapy.

Calming enlarged prostate

Initially Botox® was believed to be a product for women only. This was however proved wrong when Botox® was found to have the ability to treat enlarged prostates by relaxing the muscles. This has been of great help to many men in their early twenties who are sexually active. The drug is usually injected into the prostate thus relaxing muscles surrounding thus alleviating pressure mounted on the urethra and the irritation.

Controlling overactive muscles

Botox® has also been found to relax overactive bladders which occur due to muscles contracting frequently. The drug relaxes urinary muscles so that the feeling of constantly urinating is not there any more. Muscle spasms can be very painful, therefore Botox® is of great help to patients with this disorder.

A number of medical practitioners in Calgary, Alberta, Canada have found Botox® to be safe enough and can be used to treat many physical anomalies. However, it is important to take note that Botox® does not cure. It usually provides a temporary solution for the problem and in case a patient needs a long-term type of treatment, consulting a doctor would be the best thing to do.

Is Botox Right for You?

Is Botox® Right for You?

Is Botox Right for You?

In the past, men did not really use cosmetics to improve their appearance but this has become very normal in today’s world. There are so many products that are used by men, mostly 20 years and over as this is when the need for the cosmetic products arises. Over time, men develop crease lines or wrinkles on their face quite readily and these create the demand for the cosmetic products. The most common are horizontal wrinkles that develop on the forehead. There are several ways of getting rid of them but the most common method in Calgary, Alberta, Canada happens to be the use of Botox®.

What is Botox®?

This is a neurotoxin that is liquid in nature and is used to treat a majority of wrinkles in the face. It is administered by injection directly on the area where the wrinkles are. Once injected, Botox® relaxes the muscles and this has the effect of making the crease lines less visible. Botox® was approved by the FDA back in 2002 and since then, it has been used by many people on a global scale to attain a more appeasing and attractive youth look.

Once the Botox® has been injected into the facial muscles, it remains concentrated on those muscles alone meaning that it does not spread to other parts of the body. It has a unique way of working as it remains within the muscles for about six to seven months after the date of injection. This in turn means that one does not have to inject the Botox® again until this time has passed and the wrinkles have started appearing again. This is why most men that are above twenty years of age find it convenient for use.

How else is Botox® useful?

This product has a wide range of uses other than getting rid of frown lines that form on the forehead. In some cases, there are lines that are formed around a person’s eyes, called crow’s feet, and they are also eliminated by use of Botox®. In this case, it is injected just below the eyes where the lines are. There have also been documented cases of individual who formed lines on their necks and used Botox® to eliminate them.

What assurances does Botox® give?

A youthful look attracts so much attention and this is why many men that are approaching the thirty year bracket run to Botox®. They had been used to having smooth faces without crease lines, wrinkles and squint lines but as they get older, all these lines and even more develop. A visit to their doctors brings hope as the doctor assures them that Botox® will get the job done without much of a hustle.

True to the doctor’s word, once the injection is made and the facial muscles relax, the patient almost forgets their true age as they appear younger and more youthful. The fact the Botox® is easy to administer, last for a number of months while in active condition and is approved by the FDA gives a person all the assurance needed that it is a good product, especially for men above the age of twenty.

When is it time for Botox treatments?

When is it Time for Botox®?

When is it time for Botox treatments?

Men and women have been fighting signs of ageing for decades, and medical advances have begun to give us the tools necessary to successfully battle the signs. The question that many men and women in their twenties and up often have though is, when is it time for Botox®?

Botox® has been adopted by men and women as a powerful tool to help fight signs of aging, especially wrinkles.

The most important thing to remember when you are thinking about Botox® though is the fact that you are never too young to start utilizing the product. There are many men and women in big cities all across the world, from Los Angeles, California to Calgary, Alberta developing signs of ageing at much younger ages. The problem is that many of them do not realize that the time to start preventing ageing; is sooner rather than later.

Young men and women in their 20’s, and in some cases even younger, are developing common ageing signs which Botox® can help both prevent, and eliminate. These signs include visible wrinkle lines that appear on your forehead, between the brows of your eyes, and around the rest of your face. An experienced dermatologist, no matter how young or old you are, can assist you with Botox® and help take away your ageing wrinkles before they get worse.

If you are a young man or woman, you also should truly take into account the genetics that you have, by looking at both your father as well as your mother. If you have parents that are showing signs of wrinkles in in their thirties, then you can also use Botox® as a preventative measure to start to battle ageing before it really kicks into gear. Your genes can really dictate how you will age over time, just as they are used to help predict diseases later in life. This is why experts are beginning to recommend Botox® earlier on in your life.

Preventative Botox® is starting to become quite popular all across the world for both men and women, who are realizing that it is easier to prevent ageing before it happens, rather than to try and reverse it after the negative effects can already been seen. Preventative Botox® means that you begin to get the treatments prior to starting to show wrinkles all over your face. This may seem to go against the grain, but the thought process behind it makes sense. You can keep your face looking consistently young, without developing the wrinkles first, only to try and get rid of them later.

Everyone wants to feel vibrant and young, and self-confidence is a major part of that. When you get up in the morning and you look in the mirror, the face that stares back should be one that you are proud of, and one that gives you positive self-esteem to face anything. So the next time you ask, when is it time for Botox®? Remember that no matter how old or young you are, you can use this great tool to both prevent, and reverse visible signs of ageing, to feel better about yourself.

Botox for Men in Calgary, Edmonton and Red Deer.

Skin Care Essentials: Botox® for Men

Botox for Men in Calgary, Edmonton and Red Deer.

In the twentieth century, application of botulinum toxin, also known as Botox®, have been rampant particularly among celebrities and to those who were able to afford this particular type of treatment early on. These days, men in their twenties and above have learned to benefit from a Botox®  treatment just as their female counterparts have done for decades. With the advancement of technology these days, looking young is as easy as 1 2 3 for either sexes.

What is Botox®?

Technically, Botox® is a drug that can block the release of the neurotransmitter acetylcholine resulting in interference of muscle contraction. Medically proven, it is also used in treating severe muscle spasms or severe, uncontrollable sweating but for others, its main purpose is for cosmetics.

How to Apply Botox®? How Long Will It Take Effect?

Only little amount is injected into the area of the face to stop the contraction of muscles, soften the frown lines temporarily and block your nerve impulses. This is a fast treatment that will only take 15 minutes and you will see results within a week that could last for up to 4 to 6 months.

Botox® Treatment for Men?

Many women have been undergoing Botox® since they are held to have a higher-aging standard but just recently, Botox® for men boosted its rate 258 percent from the past decade. Why? Male patients are much more concerned with regards to their appearance lately. This is due to the fast changing economy. More men engage in Botox® treatment because it helps them become more appealing to the media and gain more advertisements. Have you ever wondered who among your favorite male celebrity had already undergone Botox®?

Advantages of Botox® Treatment

Men in the twenties are more engaged in having Botox® and other cosmetic treatment and it increases yearly. Studies show that men also turned into cosmetics because they could make them feel young and healthy, too.

Here’s a list of the benefits of Botox® Treatments:

  • It can help in preventing headaches and migraines
  • It corrects eye conditions such as; strabismus (cross-eyes); diploma (blurred vision); and blepharospasm (eyelid spasms)
  • Injecting Botox® in the bladder can help it to increase in volume thereby reducing incontinence.
  • It is also good for people who are suffering from excessive sweating.
  • Its effects can lift your mood. That’s why undergoing Botox® makes a person not only look good but happy as well.
  • It can help fight allergies.
  • It can prevent or diminish scars.

With these benefits, men from around the world and in Canada are attracted to this treatment. In addition, Botox® use by men is skyrocketing annually and this only proves that cosmetics are not only for women but also for men. So, if you fear that you will be judged because of being vain, then don’t. Men have all the same reasons to improve their appearance as women do.

What is Botox, Xeomin, Dysport?

FDA Approves Xeomin for Upper Limb Spasticity

December 23, 2015

Xeomin (incobotulinumtoxinA, Merz North America) has received FDA approval for the treatment of upper-limb spasticity (ULS) –– the abnormal head position and neck pain that occurs with cervical dystonia in adults. In clinical studies, treatment with Xeomin in adults with ULS resulted in statistically and clinically significant improvements in muscle tone.

Xeomin was first approved in August 2010 for the treatment of adults with cervical dystonia and blepharospasm.

The safety and efficacy of Xeomin were evaluated in phase III clinical studies involving more than 400 adults with ULS. The approval of Xeomin for the treatment of ULS in adults was based on results from a randomized, placebo-controlled trial in which subjects experienced significant improvements in two co-primary outcome measures: muscle tone (Ashworth Scale score) and the Investigator’s Global Impression of Change of the Primary Target Clinical Pattern (PTCP) at week 4. Both parameters showed statistical significance (P < 0.001 and P = 0.003, respectively). The trial also met a key secondary outcome measure, in which subjects with an improvement of 1 or greater on the Ashworth Scale at week 4 were classified as responders (P < 0.001).

Treatment-related adverse events were reported in 3.8% and 1.9% of subjects treated with Xeomin or placebo, respectively. The most common adverse events observed with Xeomin included seizures (3%), nasopharyngitis (2%), dry mouth (2%), and upper respiratory tract infection (2%).

Xeomin is injected into muscles. It is used to treat increased muscle stiffness in the arms of adults with ULS and blepharospasm in adults who have been treated with onabotulinumtoxinA (Botox, Allergan, Inc.).

P&T Community

Look How Far We’ve Come

When the American Academy of Facial Esthetics (AAFE) was founded over eight years ago and expanded into dentistry, people thought we were crazy. Teaching botulinum toxin (Botox/Xeomin) and dermal fillers for use by dental professionals seemed crazy at the time, even though Botox already had a long yet limited history in dentistry for the treatment of TMJ and orofacial pain.

I am very appreciative to those first dental state board members who saw the future and had the foresight to affirm the use of these pharmaceutical agents within the scope of dental practice. When you take a look at the legal language of nearly every dental practice act, botulinum toxin and dermal fillers are no different than lidocaine or antibiotics when used in the oral and maxillofacial areas; they are within the scope. The AAFE has trained dozens of dental state board members over the years.

These dental board members understood the benefits these agents could provide to patients in the areas of orofacial pain, TMJ therapy, bruxism, and esthetic dentistry. When looking at the 20-plus-year safety record that botulinum toxin and dermal fillers have, it’s easy to see that these pharmaceuticals are safer than just about anything used in dentistry, especially local anesthetics, which are much more toxic to patients than botulinum toxin.

It goes without saying that dermatologists and plastic surgeons were unhappy with the increased use of Botox and fillers by dental professionals as part of a classic turf war based purely on economics. For some strange reason, even some oral surgeons joined this turf war. Dentists are highly trained professionals, and unfortunately we’ve kept this a secret and haven’t garnered the respect we should have from fellow professionals. Now that so many dentists are providing Botox and dermal fillers, these are facts that other professionals cannot ignore. Through the AAFE’s efforts, it is now well accepted that dental clinicians can provide equal and often better patient treatment because of our familiarity with head and neck anatomy and dento-facial esthetics.

Botulinum toxin and dermal filler training now takes place at many national, regional, state, and local dental societies and dental universities. Over the last eight years, the AAFE and I have presented continuing education, including live patient training courses, at over 60 dental societies and universities, including the ADA Annual Meeting, AGD annual session, the Hinman, the Chicago Midwinter Meeting, Greater New York, and many others.

Look how far we have come. Thanks to the efforts and forward thinking of Dean Joel Berg of the University of Washington School of Dentistry, botulinum toxin and dermal fillers are now part of the undergraduate dental curriculum, and dental students perform hands-on therapeutic and esthetic training. If I had told you this eight years ago when the AAFE started that dental students would be using Botox in dental school as part of their curriculum, I would have been (and was) laughed out of the room. This is real progress for dentistry and better dental treatment.

The AAFE has now pioneered and integrated the use of botulinum toxin and dermal fillers with many other dental therapies, including dental esthetics, orofacial pain, TMJ trigger point therapy, bruxism monitoring and therapy, dental implants, and dental sleep medicine. This evidence-based research and education has now made its way through all levels of dental education, from undergraduate to high-level postgraduate continuing education. Is it safe to say that Botox and fillers are now considered part of dentistry? Of course it is. It’s time for you to become trained so your patients can get better treatment outcomes than ever before, and you can significantly grow your practice.

Louis Malcmacher, DDS, MAGD


Xeomin® Vs. Botox®: Merz Aesthetics Announces Primary Endpoint Met

March 19, 2015

Merz Aesthetics Announces Primary Endpoint Met in Post-Market Clinical Study of Xeomin® Vs. Botox® for Glabellar Facial Lines

Merz Aesthetics, a division of Merz North America (US affiliate of the global Merz Pharma Group), today announced positive results from a post-market, parallel group clinical trial designed to evaluate the efficacy of Xeomin® (incobotulinumtoxinA) in the treatment of moderate to severe glabellar facial lines, when compared to Botox® Cosmetic (onabotulinumtoxinA).

“We are pleased that data from our most recent post-market study further demonstrates the efficacy of Xeomin® (incobotulinumtoxinA),” stated Jim Hartman, Vice President and Head of U.S. Aesthetics/OTC for Merz North America. “Merz remains dedicated to providing our physician partners with clinical data that they need to choose and apply the treatment options that result in desired outcomes for their patients.”

Results show that this trial met its primary efficacy endpoint, defined as ≥ 1-point improvement from baseline on the Facial Wrinkle Scale (FWS) at maximum frown, 1 month after a single treatment. Similar efficacy profiles were demonstrated between the two treatment groups at all timepoints (1, 2, 3 and 4 months post-treatment). The most common adverse events seen in both treatment groups were headache, infection and facial asymmetry.

“The results of this clinical trial offer evidence that there are multiple effective options for injectors and patients seeking a neurotoxin for aesthetic use,” said Dr. Fredric Brandt, MD, co-lead investigator and board-certified dermatologist with private practices in Manhattan and Miami. As one of the world’s foremost leaders in injectables, Dr. Brandt has spent years developing innovative methods, new injection techniques and novel uses and benefits that have gained him a reputation as a pioneer within the skincare industry.

Botulinum toxin type A is a well-established treatment for glabellar frown lines. In 2011, Xeomin® (incobotulinumtoxinA) was approved by the FDA for improvement in the appearance of moderate-to-severe glabellar frown lines with a recommended dosage of 20 units (U). Head-to-head comparison studies conducted worldwide have demonstrated that Xeomin® (incobotulinumtoxinA) and Botox® (onabotulinumtoxinA) result in comparable safety and efficacy for both cosmetic use and therapeutic uses, including blepharospasm and cervical dystonia1.

“This data is consistent with previously published head-to-head comparison studies and demonstrates that Xeomin®(incobotulinumtoxinA) and Botox® (onabotulinumtoxinA) result in similar efficacy and safety profiles for the treatment of glabellar facial lines,” stated Dr. Michael Kane, MD, co-lead investigator on the study. A board-certified plastic surgeon in private practice in Manhattan, Dr. Kane frequently lectures on topics relating to aesthetic plastic surgery and has published hundreds of papers throughout his career.

“Given the fact that this is the first large, multicenter, parallel-group study to investigate the comparable efficacy of Xeomin® (incobotulinumtoxinA) to Botox® (onabotulinumtoxinA) in the treatment of glabellar frown lines, these study results have meaningful implications for patients and physicians alike,“ stated Dr. Michael Gold, MD, FAAD. Dr. Gold was one of the study’s key investigators, enrolling and following the largest group of patients throughout the trial. In addition to his work as a board-certified dermatologist and dermatological surgeon in private practice in Nashville, Tennessee, Dr. Gold also serves as an Assistant Clinical Professor of Dermatology at the Vanderbilt University School of Medicine. He plays an integral role in the development of new pharmaceutical products and medical devices through his clinical research, and presents regularly at national and international dermatology and cosmetic meetings.

Complete analysis of the data from this clinical trial is in progress, and Merz Aesthetics looks forward to presenting study results at an upcoming scientific conference, as well as to submitting data to a peer reviewed journal.

Mariana Smith, Business Wire

Ipsen Gets FDA Approval for Dysport & Upper Limb Spacticity

July 20, 2015

Ipsen Gets FDA Approval for Dysport for Injection to Treat Upper Limb Spasticity in Adults

Ipsen Biopharmaceuticals has received approval from the US Food and Drug Administration (FDA) for its supplemental Biologics License Application (sBLA) for Dysport (abobotulinumtoxinA) to treat upper limb spasticity (ULS) in adult patients.

Dysport is now approved to treat ULS in adults to decrease the severity of increased muscle tone in elbow flexors, wrist flexors and finger flexors.

The company said that clinical improvement may be expected one week after administration of Dysport.

A majority of patients in clinical trials were retreated between 12 and 16 weeks; some patients had a duration of response as long as 20 weeks.

The approval was based on a clinical trials conducted in more than 600 patients.

In the Phase III pivotal trial, a total of 238 adult patients with upper limb spasticity participated in the study for up to one year.

The international, multi-center, double-blind, randomized, placebo-controlled trial compared the efficacy of Dysport versus placebo in hemiparetic patients following stroke or brain trauma.

The study also included patients who were botulinum toxin naïve or previously treated with a botulinum toxin, encompassing a broad patient population.

The Dysport Phase III trial was the first registration study to evaluate ULS treatment in adults with both stroke and traumatic brain injury.

Ipsen Biopharmaceuticals CEO Cynthia Schwalm said: “It is estimated that 1.8 million adult Americans may suffer from spasticity1234, which in the upper arm can cause muscle stiffness, flexing, spasms, twitching and pain.

“We are pleased to offer another treatment option for those individuals with upper limb spasticity, a debilitating condition that often comes on the heels of a traumatic health event such as a stroke or brain injury.

“Spasticity can have a profound impact on adult patients and their abilities to perform the most basic daily tasks. Ipsen is committed to providing these patients, their caregivers and physicians with a comprehensive support offering including Dysport, the Ipsen Cares patient assistance program, and the C.L.I.M.B. injector training platform for healthcare providers.”

Data from the Phase III trial showed that those treated with Dysport demonstrated statistically significant improvement in muscle tone measured by the MAS and a significantly higher physician-rated clinical benefit measured by the PGA versus placebo at Week 4.

Staff Writer, Pharmaceutical Business Review

Botox and Sunglasses Combat Squinting

June 30, 2015

With the start of the summer season, most Floridians are planning to be outside significantly more than they were in the winter and spring. What comes along with the sunshine of the beach, barbecues and afternoons at the ball field? Squinting.

So what. Why is squinting a big issue?

Squinting is a physiologic reflex to bright environments that decreases the size of the opening of the eyelid in order to allow less light to reach the eye. Let’s examine exactly what happens during a squint. Three important facial muscle groups contract. This creates radial wrinkling of the skin and soft tissue around the eye. People will commonly call these by the nickname “crow’s feet,” or “smile lines.” The space between the eyes is narrowed creating both vertical wrinkles many call “11 lines” or “frown lines” as well as one or more horizontal lines at the top of the nose. Besides the extra wrinkles it creates, the act of squinting also lowers the position of the eyebrow.

So what does all this mean?

Over time, the pattern of repeated squinting can result in an increased number and increased depth of wrinkles between the eyes and to the sides of the eyes. This is simply the effect of creasing the skin over and over, similar to what one sees when they fold a sheet of paper in the same place many times. Squinting also encourages a lower brow position.

Of course, the sun can’t take all the blame. As we age, the skin gets progressively thinner, and changes in vision, such as need for reading glasses, can be responsible for many of the squints performed throughout the day even if one is not out in the sun.

Unfortunately, squinting from the sun is a double whammy, as it has been scientifically proven that harmful UV rays independently cause the skin to become even thinner and less elastic, in addition to increasing the risk of skin cancer.Folding skin that is thinner with less ability to stretch will result in deeper, more etched in creases over time. By now, everyone knows that sunscreen will help protect against thinning of the skin, but it doesn’t keep us from squinting. Even after applying sun protection, younger patients may notice that they get specific patterns of tan lines where they have been over using the muscles around the eyes while out in the sun.

So, does Botox® help with squinting?

Yes. Botox® helps to decrease squinting. Botox® treatments by your doctor involve placing small amounts of medicine into specific areas of these key muscles to strategically weaken the contraction in a favorable manner. This requires precision and skill to positively affect both the aesthetics and the function of the muscles around the eye. The benefit is that it significantly reverses these signs of aging. Numerous studies have proven Botox® can decrease the depth and number of wrinkles around the eyes, as well as can slightly raise the position of the brow. It can slightly open or widen the space between the eyes to give a more youthful or rested appearance.

Does that mean that if I get Botox® I shouldn’t wear sunglasses?

No way. Sunglasses are important too, as they protect the actual globe from harmful UV rays. This can potentially lower the chance of developing cataracts, macular degeneration and other eye diseases whose risk specifically increases with increased exposure.

If you have tried Botox® in the past, but didn’t like it, or didn’t see a difference, ask about other FDA approved neuromodulator medications that may work better for you, called Xeomin® and Dysport®.

Dr. Scott Asher, Tallahassee Democrat